Neurovascular Age-related Macular Degeneration
1 clinical trials · Condition
◉ Watch Neurovascular Age-related Macular Degeneration
| Record | Firm | Date |
|---|---|---|
| A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India (NCT05834075) | Novartis Pharmaceuticals | 2022-01-05 |
Track Neurovascular Age-related Macular Degeneration automatically
Every clearance here is in the API, with alerts when new ones post.